Related Experiment Video
Updated: Apr 27, 2026
Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?
Gabriel Cara-Fuentes1, Clive H Wasserfall, Heiman Wang
1Division of Pediatric Nephrology, Department of Pediatrics, University of Florida, 1600 SW Archer Rd., HD214, Gainesville, FL, 32610, USA.
Background:
Minimal Change Disease (MCD) is associated with CD80 expression in podocytes and elevated urinary CD80 excretion during active renal disease. We have evaluated the urinary excretion of CTLA-4 and CD80 during different stages of the nephrotic syndrome in patients with MCD to test the hypothesis that persistent increased urinary CD80 excretion in patients with MCD in relapse is due to an ineffectual CTLA-4 response of the host to curtail the activation of CD80.
Methods:
Thirty-two children with biopsy-proven MCD were studied during relapse and/or remission. Eleven healthy subjects served as controls.
Results:
Urinary CD80 excretion was significantly increased in MCD patients in relapse relative to that in MCD patients in remission (p < 0.001) and controls (p < 0.001). Although urinary CTLA-4 excretion was higher in MCD patients in relapse than in MCD patients in remission (p = 0.01) and controls (p = 0.03), no significant correlation was observed between urinary CD80 excretion and urinary CTLA-4 level in MCD patients at the time of relapse (p = 0.06). At the time of remission, CD80 had decreased significantly in all patients, but CTLA-4 levels either decreased or remained unchanged in all but five patients, and no correlation was observed between urinary CD80 excretion and CTLA-4 level (p = 0.7).
Conclusions:
Urinary CTLA-4 levels do not correlate with urinary CD80 excretion, suggesting the possibility that the CTLA4 response may be suboptimal in this disease during relapse.
Insights
In Minimal Change Disease (MCD), elevated urinary CD80 excretion during relapse does not correlate with CTLA-4 levels. This suggests a potentially suboptimal CTLA-4 response in active MCD.
Area of Science:
- Nephrology
- Immunology
- Pediatrics
Background:
- Minimal Change Disease (MCD) is linked to podocyte CD80 expression and increased urinary CD80 during active disease.
- The role of CTLA-4 in modulating CD80 activity in MCD requires further investigation.
Purpose of the Study:
- To evaluate urinary excretion of CTLA-4 and CD80 in children with MCD during relapse and remission.
- To test the hypothesis that increased urinary CD80 in MCD relapse is due to an inadequate CTLA-4 response.
Main Methods:
- Studied 32 children with biopsy-proven MCD during relapse and/or remission.
- Included 11 healthy children as controls.
- Measured urinary CD80 and CTLA-4 excretion levels.
Main Results:
- Urinary CD80 was significantly higher in MCD patients during relapse compared to remission and controls.
- Urinary CTLA-4 was also elevated in MCD relapse but did not correlate with CD80 levels.
- CD80 levels decreased in remission, while CTLA-4 levels remained unchanged or decreased, with no observed correlation.
Conclusions:
- Urinary CTLA-4 levels do not correlate with urinary CD80 excretion in MCD patients.
- Findings suggest a potentially suboptimal CTLA-4 response during MCD relapse.
- Further research is needed to understand the immune dysregulation in MCD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:24Nephrotic Syndrome I : Introduction
01:28Diabetic Nephropathy
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...